Invention Grant
- Patent Title: Immunity enhancing agent for cancer by Allergin-1 antagonist
-
Application No.: US15757452Application Date: 2016-09-02
-
Publication No.: US11638744B2Publication Date: 2023-05-02
- Inventor: Shiro Shibayama , Hiroshi Arima , Takuya Simbo
- Applicant: ONO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Osaka
- Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee: ONO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Osaka
- Agency: Sughrue Mion, PLLC
- Priority: JPJP2015-173659 20150903,JPJP2016-138374 20160713
- International Application: PCT/JP2016/075887 WO 20160902
- International Announcement: WO2017/038997 WO 20170309
- Main IPC: A61K38/17
- IPC: A61K38/17 ; C07K14/705 ; A61K45/06 ; A61K38/00 ; A61K45/00 ; A01K67/027 ; A61P35/02 ; C07K16/28 ; A61K39/00 ; A61K39/395
Abstract:
A method for suppression of progress of, suppression of recurrence of and/or treatment of cancer, by administering an Allergin-1 antagonist in a therapy of a cancer patient with insufficient therapeutic efficacy by a tumor immunotherapeutic agent, or a cancer therapy in combination with an anti-cancer drug.
Public/Granted literature
- US20180244771A1 IMMUNITY ENHANCING AGENT FOR CANCER BY ALLERGIN-1 ANTAGONIST Public/Granted day:2018-08-30
Information query
IPC分类:
